In a community-based sample of seropositive adults (n = 1101), we found that seropositive individuals who lived with a known coronavirus disease 2019 (COVID-19) case exhibited higher blood anti-severe acute respiratory syndrome coronavirus 2 spike receptor-binding domain immunoglobulin G concentrations and greater symptom severity compared to seropositive individuals who did not live with a known COVID-19 case.
Keywords: immunity; severe acute respiratory syndrome coronavirus 2; transmission.
© The Author(s) 2021. Published by Oxford University Press on behalf of Infectious Diseases Society of America.